Previous 10 | Next 10 |
Investors sold off shares of several coronavirus vaccine-related stocks on Friday as lawmakers ramp up pressure on drugmakers. By the close of trading, shares of Vaxart (NASDAQ: VXRT) , Inovio Pharmaceuticals (NASDAQ: INO) , BioNTech (NASDAQ: BNTX) , and Moderna (NASDAQ: MRNA) we...
Many big drugmakers launched programs earlier this year to fight COVID-19. But the biggest winners for investors have been the stocks of small coronavirus-focused biotechs. Two that particularly stand out are Sorrento Therapeutics (NASDAQ: SRNE) and Vaxart (NASDAQ: VXRT) . Sorr...
With the coronavirus pandemic gripping the world, governments everywhere are desperate to speed up the discovery of a vaccine. In the U.S., since May, this dire need has been addressed by a vaccine accelerator project called Operation Warp Speed (OWS), which subsidizes public and private compani...
NetworkNewsWire Editorial Coverage : Effective pandemic response relies first and foremost on fast and accurate testing to buy time and save lives while therapeutics and vaccines are developed. Coronavirus cases continued to surge in the US this month, showing no signs of slowing since lock...
The world is desperate for a COVID-19 vaccine. The U.S. government is giving away billions of dollars in grant money in the hopes that somebody, anybody, will find a vaccine that works and will defeat this awful disease. And so far, anyway, investors in this sector have done well. In the first ...
You could play it safe. Put your money in assets that aren't likely to lose their value. Maybe you might opt to buy shares of utility companies that enjoy monopolies. But not every investor wants to take the safe path that leads to smaller returns over the long run. Even normally risk-ave...
Neither Novavax (NASDAQ: NVAX) nor Vaxart (NASDAQ: VXRT) is at the head of the pack of drugmakers developing COVID-19 vaccine candidates. However, both stocks are way ahead of most of their rivals. Novavax shares are up close to 2,700% year to date; Vaxart stock has skyrocketed over 4,...
Reuters reports that the European Union (EU) is negotiating with Moderna (NASDAQ: MRNA ) , Sanofi (NASDAQ: SNY ) , Johnson & Johnson (NYSE: JNJ ) , BioNTech (NASDAQ: BNTX ) and CureVac for advance purchases of their respective COVID-19 vaccines. The EU shared the information yeste...
Shares of Vaxart (NASDAQ: VXRT) are up by 13.2% as of 11:14 a.m. EDT on Thursday, after the company announced the publication of a new study that estimates the annual cost of norovirus gastroenteritis in the U.S. The data from the study in question, published in the Journal of Infectious Di...
SOUTH SAN FRANCISCO, Calif., July 16, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc., (NASDAQ: VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, and has a Phase 2 ready norovirus vaccine program, today announc...
News, Short Squeeze, Breakout and More Instantly...
Antibody rise observed in lactating mothers and in their breast milk Long-term goal is to provide protection to infants through passive antibody transfer SOUTH SAN FRANCISCO, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that it has complet...
SOUTH SAN FRANCISCO, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that Dr. Sean Tucker, Founder and Chief Scientific Officer, will present at the World Vaccine Congress Washington 2024 in Washington, D.C. on Wednesday, April 3, 2024. The Company has appea...
SOUTH SAN FRANCISCO, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ:VXRT) (the "Company" or "Vaxart") today announced that the ...